AnandRathi

Bafna Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
276.60
-9.30 (-3.25%)

Bafna Pharmaceuticals Ltd (Bafna Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹654 crore.

Bafna Pharmaceuticals Ltd Overview

Market cap₹654 Crs
Volume3,496
Prev. Close₹285.90
Year range₹95.00 - ₹296.00
Total Value₹9,66,993.60
ISININE878I01022

Bafna Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)10.63%
P/E Ratio (TTM)84.07
P/B Ratio6.81
Debt to Equity0.39
ROE11.54%
EPS (TTM)3.29
Dividend Yield0.00%
Book Value40.64
Profit Margin5.46%
Operating Margin3.70%

Bafna Pharmaceuticals Ltd Historical Performance

1 Month Return11.17%
6 Month Return157.66%
3 Year Return164.49%
3 Month Return105.65%
1 Year Return179.39%
5 Year Return101.90%

Bafna Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research